By: Matthew Fischer With the rapid growth of the regenerative medicine field, the U.S. Food and Drug ..
stem cell law By: Matthew Fischer Amid the growing focus on stem cell products by the Federal Food and Drug ..
By: Matt Fischer A recent lawsuit seeking class action status that targeted Zone Program Integrity Contractor ..
By: Matthew Fischer Iowa Senator Chuck Grassley issued a press release last week indicating that he sent ..
By: Matthew Fischer Through two public channels this month, the FDA further solidified its stance on the innovative ..
By: Matthew Fischer The regenerative medicine arena consists of a wide range of innovative products. ..
By: Matthew Fischer Aside from the half million already pending before the Office of Medicare Hearings ..